Atazanavir
- Product NDC
- 69238-1136
- 11-digit product format
- 692381136
- Labeler code
- 69238
- Product ID
- 69238-1136_0564f4f6-b4d0-477e-a730-93008830bef8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atazanavir
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- ANDA209717
- Marketing category
- ANDA
- Marketing start
- 2020-06-03
- Marketing end
- 0000-00-00
- Substance
- ATAZANAVIR SULFATE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69238-1136 | ATAZANAVIR CAPSULE [AMNEAL PHARMACEUTICALS NY LLC] | 9 | Legacy NDC | 20250205_b670a844-3bbf-4d9a-9904-87992f26792d.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69238-1136-6 | 69238113606 | 60 CAPSULE in 1 BOTTLE (69238-1136-6) | 60 capsule | 2020-06-03 | 0000-00-00 | No | No | Current |